Fresenius Kabi Taiwan Ltd.
Clinical trials sponsored by Fresenius Kabi Taiwan Ltd., explained in plain language.
A subsidiary of Fresenius Kabi, providing infusion, transfusion, and clinical nutrition products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New flavored drink helps cancer patients keep weight on during treatment
Disease control CompletedThis study tested three flavors of Supportan® drink (Tropical Fruits, Cappuccino, and Pineapple-Coconut) in 123 cancer patients undergoing chemotherapy, radiotherapy, immunotherapy, or targeted therapy. Patients drank two bottles daily for four weeks alongside their normal diet. …
Sponsor: Fresenius Kabi Taiwan Ltd. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drink flavors aim to help kidney patients stay nourished
Disease control CompletedThis study tested two flavors of a high-energy, low-protein drink called Renalive® LP in 74 adults with chronic kidney disease stages 3b-5. Participants drank the formula as a meal replacement or supplement for 4 weeks. The goal was to see if the drink was suitable and helped mai…
Sponsor: Fresenius Kabi Taiwan Ltd. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC